Riskpilot← Back to searchSign inGet full accessFrostPharma Holding AB
ABActiveOrg 5594328451Berga Backe 2Activities of head offices · NACE 7010Est. 20235-9 employees
Revenue 2024
SEK 6,7M
+133% vs 2023
EBITDA margin
9.8%
+187% vs 2023
Equity ratio
99.8%
Financial strength
Net profit 2024
SEK -509K
-345% vs 2023
| Revenue | SEK 6,7M | +133% |
| EBITDA | SEK 654K | +187% |
| Net profit | SEK -509K | -345% |
| Total assets | SEK 438,3M | +46% |
| Equity | SEK 437,4M | +46% |
| Employees | — | — |
Legal name
FrostPharma Holding AB
Org number
5594328451
Legal form
Aktiebolag
NACE code
7010 · Activities of head offices
Founded
4 maj 2023
Share capital
SEK 4 242 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av Nilsson, Lena Louise Willén, Erik Karl-Johan i förening med en av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska, direkt eller indirekt, äga och förvalta aktier och andelar i dotterbolag samt tillhandahålla koncerngemensamma funktioner till sina dotterbolag såsom managementtjänster samt bedriva därmed förenlig verksamhet.
Address
Berga Backe 2
Email
info@frostpharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 2 877 | 6 690 |
| Staff expenses | — | — |
| EBITDA | 228 | 654 |
| Depreciation & amort. | −0 | −0 |
| EBIT | 228 | 654 |
| Net financials | 33 | −1 163 |
| Profit before tax | 261 | −509 |
| Tax | −53 | −0 |
| Net profit | 208 | −509 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 299 536 | 438 289 |
| Equity | 298 908 | 437 356 |
| Long-term debt | 0 | 0 |
| Short-term debt | 628 | 932 |
| Total debt | 628 | 932 |
EBITDA margin
9.8%
This company
15.8%
Market median
-38% vs market
20232024
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20232024
Return on equity
-0.1%
This company
18.4%
Market median
-101% vs market
20232024
Net profit margin
-7.6%
This company
8.1%
Market median
-194% vs market
20232024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20232024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20232024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-05-01 – 2023-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LM Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
AM Audit | Audit | 2023 | — | — |
CF Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
KK Chief Auditor | Chief Auditor | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2024 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Deputy Board Member | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Priveq Investment VI (A) AB | Company | 55.0% | 55.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Priveq Holding VI AB
FrostPharma Holding AB Board members of FrostPharma Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Magnus Nylén | Chief Executive Officer | 0 companies |
| Anna Maria Andersson | Audit | 0 companies |
| Carl Fredrik Oskar S Andersch | Chief Executive Officer | 0 companies |
| Kajsa Karin Helena Goding | Chief Auditor | 0 companies |
| Jan Anders Fredrik Lovén | Deputy Board Member | 0 companies |
| Jan Totte Dahlin | Deputy Board Member | 0 companies |
| Viktor Elias Bergman Gullmark | Deputy Board Member | 0 companies |
| Emma Maria Birgitta Wik | Deputy Board Member | 0 companies |
| Andreas Hans Eddie Ottosson | Deputy Board Member | 0 companies |
| Roger Carl-Gunnar Tapper | Board of Directors | 0 companies |
| Anna Matilda Sjödin | Deputy Board Member | 0 companies |
| Clas Fredrik Lindbergson | Board of Directors | 0 companies |
| Eva Charlotta Walde | Board of Directors | 0 companies |
| Daniel Mats Filip Nylund | Deputy Board Member | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Linn Mikaela Engman | Deputy Board Member | 0 companies |
| Rolf Allan Classon | Chairman | 0 companies |
| Emelie Sofia Bergh | Deputy Board Member | 0 companies |
| Erik Karl-Johan Willén | Board of Directors | 0 companies |
| Aline Madeleine Pettersson | Deputy Board Member | 0 companies |
| Anna Carolina Maria Bjarnhagen | Deputy Board Member | 0 companies |
| Elin Anna Margareta Spjut | Deputy Board Member | 0 companies |
| Sven Christer Ahlberg | Board of Directors | 0 companies |
| Mari Sinikka Kovaniemi Feldt | Deputy Board Member | 0 companies |
| Lena Louise Nilsson | Board of Directors | 0 companies |
| Olina Kristina Maria Wåhlstedt | Deputy Board Member | 0 companies |
| Julia Engla Eva M Arnfridsdotter | Deputy Board Member | 0 companies |
| Anna Klara Alina Bruksås Nybjörk | Deputy Board Member | 0 companies |